No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
334 |
4. Check minimum number of eventsNone |
334 |
5. Include endpointsNone |
334 |
6. Filter based on genotype QC (FinnGen only) |
334 |
Control definitions (FinnGen only)
- Control exclude
- H8_MIDDLEMASTOID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF6
- Parent code in ICD-10
- H70
- Name in latin
- Mastoiditis acuta
Similar endpoints
↥List of similar endpoints to
Acute mastoiditis
based on the number of shared cases.
Similar with more cases:
- Diseases of middle ear and mastoid
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3448 | 1399 | 2033 |
| Only index persons | 3116 | 1283 | 1833 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.04 | 0.06 |
| Only index persons | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 20.70 | 22.79 | 19.10 |
| Only index persons | 20.06 | 21.89 | 18.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 334 | 174 | 160 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.07 |
| Median age at first event (years) | 25.32 | 29.84 | 20.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 307
- Matched controls
- 3069
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H70.0
ICD-10 Finland
Acute mastoiditis
866.0
159.2
143
*
38200
ICD-8 Finland
Acute / Acute otitis media with mastoiditis
+∞
138.3
122
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
20.7
53.6
82
53
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
590.9
52.1
50
*
DC1AD
NOMESCO Finland
Temporalbone CT
118.6
30.3
32
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
171.7
30.2
31
*
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
29.7
28
*
DFF00
NOMESCO Finland
Pure tone audiometry
8.7
27.3
62
87
H65.3
ICD-10 Finland
Chronic mucoid otitis media
76.6
25.2
28
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
259.3
24.0
24
*
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
23.2
22
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
22.1
21
*
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
+∞
21.1
20
*
H66.9
ICD-10 Finland
Otitis media, unspecified
8.9
19.8
43
55
38300
ICD-8 Finland
Mastoiditis without mention of otitis media, Acute
+∞
17.9
17
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
+∞
16.8
16
*
UDC00
NOMESCO Finland
Ear microscopy
6.0
15.8
45
86
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
+∞
15.8
15
*
H65.0
ICD-10 Finland
Acute serous otitis media
89.7
15.7
17
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.6
14.7
182
1098
H60.9
ICD-10 Finland
Otitis externa, unspecified
5.0
13.1
43
97
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
+∞
12.6
12
*
3830A
ICD-9 Finland
Mastoiditis and related conditions, Acute mastoiditis
+∞
12.6
12
*
DC1BD
NOMESCO Finland
Temporal bone extensive CT
135.3
12.5
13
*
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
+∞
11.5
11
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.4
11.0
56
188
4122
FHL
Tympanostomy (tympanic tube)
+∞
10.5
10
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
10.5
10
*
DCD00
NOMESCO Finland
Myringoplasty
+∞
10.5
10
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
10.5
10
*
DEB30
NOMESCO Finland
Radical mastoidectomy
+∞
10.5
10
*
TDA90
NOMESCO Finland
Removal wax from ear
19.6
10.4
15
8
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
+∞
9.4
9
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
28.4
8.5
11
*
H70.9
ICD-10 Finland
Mastoiditis, unspecified
92.5
8.5
9
*
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
8.4
8
*
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
+∞
8.4
8
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.8
8.2
22
40
J01MA02
ATC
ciprofloxacin; systemic
2.1
8.2
118
700
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.4
8.1
74
353
H02AB04
ATC
methylprednisolone; systemic
2.6
8.0
59
253
H60.3
ICD-10 Finland
Other infective otitis externa
7.8
7.8
17
23
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
7.6
122
750
J01FF01
ATC
clindamycin; systemic
2.2
7.4
89
483
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
7.3
7
*
38204
ICD-8 Finland
NA
+∞
7.3
7
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
7.2
46
180
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
20.6
7.2
10
5
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
7.1
89
490
J01DB01
ATC
cefalexin; oral
2.2
7.1
253
2091
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
14.2
6.9
11
8
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
17.1
6.8
10
6
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.7
6.7
45
181
G51.0
ICD-10 Finland
Bell palsy
5.7
6.4
17
31
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
9.5
6.3
12
13
DCD10
NOMESCO Finland
Tympanoplasty
+∞
6.3
6
*
4144
FHL
Mastoidectomy or aticomastoidectomy
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
85
259
4.06
25.00
3.1
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
70
313
2.56
10.13
2.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
74
346
2.46
9.72
2.6
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
40
4.98
8.70
1.7
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
20
6.72
8.12
1.2
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
72
3.36
6.27
2.0
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
91
581
1.78
4.90
5.7
4.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
20
5.12
4.80
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
143
1042
1.65
4.71
2.3
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
138
1005
1.64
4.50
9.6
6.0
mmol/l
1.2
1.2
0.02
133
933
(3009445) Proteinase 3 Ab [Units/volume] in Serum
26
106
2.58
4.50
3.6
1.4
u/ml
15.3
9.2
—
5
6
(3044290) Cell count panel - Cerebral spinal fluid
15
45
3.44
4.38
1.2
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
128
923
1.63
4.31
8.5
7.2
inr
1.1
1.1
0.15
39
285
(42870588) Differential panel, method unspecified - Blood
118
853
1.59
3.85
8.3
6.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
15
51
3.03
3.62
1.2
1.6
e6/l
265.2
7.6
—
10
40
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
15
51
3.03
3.62
1.2
1.7
e6/l
8690.7
131.4
—
10
44
(3026008) Bacteria identified in Urine by Culture
89
612
1.62
3.53
3.2
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
56
343
1.76
3.41
1.8
1.7
nmol/l
988.7
1291.8
1.73
47
275
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
10
7.12
3.38
1.3
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
27
3.79
3.38
3.3
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
360
1.74
3.37
2.6
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
19
4.84
3.26
1.2
2.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
144
1121
1.50
3.24
12.1
6.6
mmol/l
1.2
1.2
0.25
121
962
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
16
5.09
3.07
1.1
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
38
214
1.88
3.03
2.1
2.3
—
8.5
—
0
12
(3037467) Urinalysis macro (dipstick) panel - Urine
206
1741
1.48
2.98
5.7
3.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
40
233
1.81
2.88
3.6
3.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
36
3.13
2.83
1.7
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
111
2.15
2.80
8.5
11.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
31
3.29
2.79
1.1
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
34
191
1.87
2.75
1.1
1.3
—
18.1
—
0
13
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
37
3.04
2.72
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
37
3.04
2.72
1.7
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
37
3.04
2.72
1.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
37
3.04
2.72
1.7
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
37
3.04
2.72
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
37
3.04
2.72
1.7
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
32
177
1.89
2.71
2.1
1.6
—
—
—
0
0
(3019225) pH of Specimen
34
195
1.83
2.58
8.9
4.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
122
2.04
2.58
2.8
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
281
2564
1.60
2.57
15.5
10.7
ml/min/173m2
85.9
87.3
0.46
240
2094
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
11
5.53
2.55
1.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
63
2.45
2.50
3.3
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
77
553
1.51
2.47
2.8
2.2
mg/l
3.3
3.0
0.26
66
480
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
27
3.40
2.41
1.1
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
123
972
1.42
2.40
7.8
5.1
g/l
35.5
36.4
0.99
114
918
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
78
565
1.50
2.40
4.0
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
84
2.21
2.39
1.9
2.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
8
6.32
2.38
5.6
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
64
445
1.54
2.38
2.7
2.4
mosm/kgh2o
554.5
580.3
0.35
56
386
(3016244) Insulin [Units/volume] in Serum or Plasma
6
13
4.68
2.28
2.8
4.0
mu/l
42.1
20.2
—
6
13
(3052851) Hemolysis interference index of Serum or Plasma
15
66
2.33
2.28
2.3
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
143
1169
1.39
2.27
5.4
3.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
67
476
1.51
2.25
2.6
2.4
e6/l
3.5
6.1
0.79
58
424
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
230
2037
1.41
2.24
3.6
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
108
2.01
2.21
4.7
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
109
854
1.41
2.20
4.6
3.1
e6/l
59.5
97.3
0.35
74
588
(3044640) Blood type and Crossmatch panel - Blood
98
756
1.42
2.16
4.3
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
34
207
1.72
2.14
3.1
3.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
68
2.26
2.14
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
37
2.76
2.12
1.8
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
94
722
1.42
2.12
2.7
2.2
u/l
211.5
201.9
0.07
86
689
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
79
588
1.45
2.11
1.9
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
281
1.61
2.08
4.6
3.8
%
32.2
30.9
0.30
37
191
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
128
1039
1.38
2.08
2.5
2.3
nmol/l
75.2
74.4
0.11
115
947
(3000991) Gas panel - Venous blood
30
178
1.75
2.07
9.4
9.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
183
1573
1.36
2.06
5.6
3.9
—
120.9
—
0
27
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
77
2.13
2.00
1.8
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
30
180
1.73
2.00
19.4
8.5
mmol/l
8.8
8.3
0.14
30
173
(3003396) Base excess in Arterial blood by calculation
36
228
1.65
1.97
9.2
8.3
mmol/l
1.3
1.3
0.03
28
180
(3014111) Lactate [Moles/volume] in Serum or Plasma
31
189
1.71
1.95
9.9
7.6
mmol/l
1.2
1.4
1.01
31
184
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
33
2.77
1.94
1.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
75
563
1.43
1.91
1.9
1.8
mg/l
0.7
1.2
1.59
60
435
(36304419) Bacteria [Presence] in Urine
85
657
1.39
1.83
4.1
2.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
12
4.21
1.83
1.2
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
12
4.21
1.83
1.2
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
12
4.21
1.83
1.2
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
33
209
1.64
1.82
9.6
8.6
%
96.3
95.4
0.41
33
201
(3030467) Casts [#/volume] in Urine by Automated count
84
649
1.39
1.81
4.1
2.6
e6/l
0.6
0.5
0.10
62
473
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
52
367
1.49
1.81
3.7
2.3
e6/l
1.3
2.7
1.34
26
184
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
139
1.78
1.81
2.2
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
88
688
1.38
1.77
5.6
4.1
ph
7.4
7.4
0.14
17
126
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
35
227
1.61
1.76
9.5
8.2
kpa
5.2
5.1
0.23
35
217
(3027801) Oxygen [Partial pressure] in Arterial blood
35
227
1.61
1.76
9.4
8.2
kpa
13.4
12.4
0.50
35
219
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
36
2.54
1.75
1.3
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
110
894
1.34
1.72
2.3
1.8
pmol/l
97.7
96.6
0.06
59
474
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
44
303
1.52
1.72
4.3
2.2
%
24.6
24.8
0.05
38
262
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
48
2.34
1.72
1.5
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
13
3.89
1.72
1.0
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
106
859
1.34
1.69
4.9
2.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
255
1.55
1.67
2.8
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
19
3.20
1.67
3.5
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
98
1.88
1.65
1.1
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
223
2012
1.33
1.64
3.7
3.9
pmol/l
14.5
14.5
0.05
207
1864
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
74
570
1.38
1.62
3.4
3.3
ng/l
1207.5
937.2
0.22
68
477
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
32
2.54
1.60
1.0
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
138
1171
1.30
1.57
12.2
9.0
e9/l
0.0
0.0
1.46
116
966
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
57
2.15
1.57
3.2
3.9
u/ml
0.3
0.3
—
7
29
(3037522) Nuclear Ab [Titer] in Serum
50
361
1.45
1.57
1.6
1.4
titre
385.0
555.1
—
8
73
(3022096) Basophils/100 leukocytes in Blood
142
1211
1.30
1.56
9.5
6.2
%
0.7
0.7
0.26
137
1144
(3022621) pH of Urine by Test strip
24
146
1.69
1.55
2.2
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
290
2735
1.46
1.54
20.3
12.0
mg/l
21.4
21.5
0.02
243
2129
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
109
898
1.32
1.54
4.7
3.4
ng/l
51.9
36.5
0.21
71
574
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.2
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
32
211
1.57
1.53
3.1
2.3
g/l
9.7
10.2
0.29
32
194
(3032773) Endomysium IgG Ab [Titer] in Serum
7
27
2.63
1.52
1.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
27
2.63
1.52
1.1
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
38
261
1.51
1.52
2.9
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
21
2.89
1.51
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
21
2.89
1.51
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
21
2.89
1.51
1.2
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
289
2726
1.45
1.51
21.8
13.0
mmol/l
139.4
139.6
0.80
281
2659
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
50
364
1.44
1.50
1.7
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
16
3.16
1.44
1.4
1.4
mmol/l
4.5
1.8
—
5
16
(3003694) ABO and Rh group [Type] in Blood
91
737
1.32
1.44
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
174
1.60
1.42
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
46
2.21
1.41
1.9
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
29
2.44
1.40
2.9
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
89
1.84
1.39
1.3
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
41
2.23
1.38
4.7
4.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
53
397
1.40
1.37
3.8
2.2
e6/l
1.3
1.3
0.01
28
213
(3005570) Glucose [Moles/volume] in Urine
6
23
2.64
1.37
1.5
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
89
724
1.31
1.36
4.0
2.7
e6/l
19.9
135.7
0.68
65
542
(3006504) Eosinophils/100 leukocytes in Blood
145
1258
1.27
1.34
9.5
6.2
%
2.7
2.8
0.49
139
1189
(3023103) Potassium [Moles/volume] in Serum or Plasma
289
2743
1.40
1.28
22.1
13.1
mmol/l
4.0
4.0
0.51
281
2673
(3013512) EKG study
80
647
1.31
1.27
4.4
3.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
148
1294
1.26
1.27
9.3
6.0
%
57.5
57.2
0.10
143
1231
(3019069) Monocytes/100 leukocytes in Blood
145
1265
1.26
1.27
9.9
6.5
%
8.8
8.3
1.00
140
1203
(3020891) Body temperature
15
85
1.80
1.25
5.7
3.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
149
1306
1.25
1.24
9.4
6.2
%
28.2
28.2
0.02
144
1237
(3002032) Base excess in Venous blood by calculation
29
197
1.52
1.24
8.2
3.9
mmol/l
1.3
2.2
0.94
22
153
(3026493) Urate [Moles/volume] in Serum or Plasma
82
668
1.30
1.24
3.6
2.6
umol/l
8108.3
5375.1
0.17
71
594
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
558
1.32
1.23
3.7
3.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
19
2.66
1.22
2.8
4.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
303
2906
1.46
1.20
17.2
10.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
220
2021
1.26
1.20
3.3
3.3
u/l
48.2
46.7
0.11
208
1932
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
64
1.91
1.19
1.4
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
38
2.13
1.19
1.3
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
38
2.13
1.19
1.3
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
95
1.72
1.16
1.4
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
95
1.72
1.16
1.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
65
1.88
1.15
1.4
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
143
1259
1.24
1.12
3.4
3.1
estimate
0.0
0.0
0.00
34
233
(3014051) Protein [Presence] in Urine by Test strip
8
41
1.97
1.09
2.1
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
59
1.89
1.08
1.5
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
50
387
1.34
1.08
2.7
2.7
mmol/l
2.5
2.4
0.73
39
339
(3007164) IgA [Mass/volume] in Serum or Plasma
72
588
1.29
1.07
1.7
1.3
g/l
2.1
2.4
0.77
46
381
(3004588) Protein electrophoresis panel - Serum or Plasma
20
130
1.57
1.05
2.5
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
114
1.61
1.05
1.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
44
336
1.36
1.04
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
22
2.29
1.03
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
83
1.72
1.03
1.1
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
92
778
1.25
1.03
3.8
3.3
mmol/l
2.4
2.4
0.06
82
704
(3002256) Pathology report gross observation
42
319
1.36
1.03
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
259
2443
1.27
1.03
4.6
4.5
mu/l
2.0
1.8
0.54
240
2280
(3037121) Protein [Mass/volume] in Urine
15
91
1.68
1.02
6.5
3.5
g/l
0.4
0.2
—
8
44
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
232
1.42
1.02
1.2
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
76
1.74
1.00
2.5
2.4
—
—
—
0
0
(3039000) Anion gap in Blood
9
50
1.82
0.97
12.1
7.6
mmol/l
11.3
10.8
—
9
44
(3018572) Chloride [Moles/volume] in Blood
9
50
1.82
0.97
12.1
7.6
mmol/l
106.3
105.3
—
9
44
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
50
1.82
0.97
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
61
495
1.28
0.95
1.7
1.4
nmol/l
19.1
21.6
0.92
56
422
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
52
1.75
0.93
1.2
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
453
1.28
0.90
5.9
3.2
ng/l
178.9
410.5
0.43
41
326
(3022217) INR in Platelet poor plasma by Coagulation assay
36
273
1.36
0.90
42.6
18.6
inr
1.3
1.2
—
5
43
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
42
1.93
0.89
2.5
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
43
1.88
0.88
1.3
1.2
—
—
—
0
0
(4035726)
28
205
1.40
0.86
1.7
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
141
1266
1.20
0.86
4.9
4.2
estimate
0.0
0.0
0.50
36
235
(3042631) Mycobacterium sp identified in Specimen
6
31
1.95
0.85
3.7
3.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
46
1.76
0.83
6.4
2.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
147
1330
1.19
0.82
7.3
6.4
umol/l
10.0
10.9
0.74
140
1275
(3023183) Ammonium ion [Moles/volume] in Plasma
8
47
1.72
0.81
3.0
5.0
umol/l
30.4
37.6
—
8
41
(3008152) Bicarbonate [Moles/volume] in Arterial blood
19
131
1.48
0.80
11.9
6.7
mmol/l
24.0
24.9
0.68
19
122
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
360
1.29
0.80
1.7
1.7
—
—
—
0
0
(4062490)
6
33
1.83
0.79
5.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
98
0.50
0.79
1.2
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
78
668
1.22
0.78
3.3
3.4
estimate
0.0
0.0
0.68
34
229
(3001122) Ferritin [Mass/volume] in Serum or Plasma
131
1179
1.18
0.77
4.2
2.7
ug/l
122.8
115.0
0.15
118
1110
(3039443) Prostate specific Ag panel - Serum or Plasma
14
91
1.56
0.76
1.2
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
208
1946
1.18
0.76
5.0
3.8
mm/h
10.2
9.8
0.21
197
1829
(3013115) Eosinophils [#/volume] in Blood
151
1376
1.18
0.76
9.4
6.7
e9/l
0.2
0.2
0.09
136
1234
(3009261) Glucose [Presence] in Urine by Test strip
141
1278
1.18
0.76
3.5
3.1
estimate
0.0
0.0
0.00
34
220
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
54
1.68
0.75
1.4
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
147
1338
1.18
0.75
9.3
6.3
e9/l
0.6
0.6
1.25
131
1177
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
38
1.86
0.74
2.1
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
151
1379
1.17
0.73
9.1
6.3
e9/l
1.9
2.0
0.06
136
1237
(3006315) Basophils [#/volume] in Blood
147
1340
1.17
0.73
9.3
6.4
e9/l
0.0
0.0
0.28
131
1184
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.0
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
26
1.94
0.71
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
94
830
1.18
0.68
4.1
2.7
u/l
53.7
55.3
0.19
88
781
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
54
452
1.23
0.67
1.6
1.7
pmol/l
475.3
20960028.4
0.50
45
396
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.0
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.8
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
18
129
1.42
0.65
9.1
4.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
36
440
0.80
0.61
1.2
1.8
%
1.2
1.4
1.69
28
397
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
21
0.00
0.60
0.0
2.8
—
34.1
—
0
21
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
35
1.73
0.58
5.0
5.0
umol/l
459.5
340.9
—
6
26
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
35
1.73
0.58
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
32
257
1.27
0.58
1.5
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
82
1.48
0.55
1.2
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
83
739
1.16
0.55
2.8
2.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
39
1.55
0.53
12.0
2.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
30
242
1.26
0.53
4.0
2.4
u/l
33.2
33.5
0.01
25
206
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
57
493
1.19
0.53
2.2
2.5
ug/l
0.8
0.7
0.16
26
268
(3009542) Hematocrit [Volume Fraction] of Blood
271
2623
1.18
0.53
18.7
12.4
%
40.4
41.0
0.50
225
2116
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
40
1.51
0.52
1.3
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
224
0.75
0.51
2.2
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
234
1.26
0.51
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
300
2932
1.23
0.50
12.1
9.6
u/l
28.3
28.4
0.02
292
2865
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
209
1992
1.13
0.49
10.1
7.4
u/l
80.4
75.4
0.69
199
1883
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
291
1.23
0.49
1.3
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
469
1.18
0.48
1.5
1.2
iu/ml
14.5
30.0
2.20
17
161
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
46
1.53
0.48
2.7
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
316
3108
1.31
0.47
26.5
17.5
e12/l
4.6
4.6
0.38
308
3034
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
120
1.35
0.47
2.5
2.5
u/l
2408.0
3711.3
—
8
38
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
48
1.47
0.47
1.1
1.0
—
17.4
—
0
5
(3010813) Leukocytes [#/volume] in Blood
316
3109
1.30
0.46
26.5
17.6
e9/l
6.9
6.6
1.93
309
3033
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
90
817
1.14
0.46
3.5
3.8
ug/l
1.4
1.8
1.19
80
748
(3023511) Choriogonadotropin [Units/volume] in Urine
10
69
1.46
0.44
1.2
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
31
1.62
0.43
2.8
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.8
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
139
0.71
0.43
1.9
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
72
648
1.14
0.42
1.2
1.3
u/ml
1.0
1.0
0.02
21
176
(3008898) HLA-B27 [Presence]
10
138
0.72
0.41
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
123
1.32
0.41
1.6
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
60
1.34
0.40
2.0
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
43.5
—
0
8
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
651.9
—
0
8
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
277.4
—
0
8
(40760892) CBC W Ordered Manual Differential panel - Blood
58
649
0.87
0.40
4.5
5.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
71
1.42
0.39
1.3
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
19
0.00
0.39
0.0
9.1
—
38.1
—
0
8
(21494755) Public health laboratory ask at order entry panel
35
407
0.84
0.39
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
42
365
1.17
0.39
1.9
2.6
ug/g
115.7
131.4
0.16
35
296
(3003740) Influenza virus B Ag [Presence] in Specimen
9
67
1.35
0.38
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
67
1.35
0.38
1.0
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
315
3105
1.25
0.38
26.6
17.6
e9/l
252.5
253.0
0.05
309
3036
(40758558) Short blood count panel - Blood
73
663
1.13
0.37
11.0
7.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.8
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
179
0.77
0.36
1.8
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
77
0.64
0.36
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
1016
1.11
0.36
3.3
3.1
—
—
—
0
0
(4094501)
5
78
0.64
0.36
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
38
435
0.86
0.36
2.4
2.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
163
1551
1.10
0.35
11.9
9.7
e9/l
4.3
4.0
0.87
142
1370
(3025159) Blasts/100 leukocytes in Blood
15
189
0.78
0.35
4.5
5.0
%
0.0
0.2
—
8
52
(3045424) Erythrocytes [Presence] in Urine
6
43
1.40
0.35
1.2
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
52
465
1.14
0.34
1.9
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
72
658
1.12
0.34
2.7
3.5
%
20.0
21.7
0.33
22
258
(1616796) Gas panel - Central venous blood
6
45
1.34
0.34
5.0
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
46
1.31
0.33
1.3
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
111
1.27
0.30
1.2
1.4
miu/ml
91.1
263.2
—
7
55
(3023520) Reticulocytes [#/volume] in Blood
19
157
1.22
0.30
2.7
3.6
e9/l
78.5
73.7
0.14
13
120
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
56
1.26
0.29
1.1
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
12
94
1.29
0.28
10.0
4.9
%
2.1
1.6
0.53
12
87
(3044889) 12 lead EKG panel
191
1848
1.08
0.26
3.8
3.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
72
1.26
0.26
1.8
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
82
0.73
0.24
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
82
0.73
0.24
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
82
0.73
0.24
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
82
0.73
0.24
1.3
1.4
—
—
—
0
0
(4034850)
6
84
0.71
0.24
9.3
9.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
449
1.11
0.23
1.3
1.3
u/ml
31.4
9.1
0.68
19
184
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
231.1
—
0
11
(3013727) Leukocytes other/100 leukocytes in Blood
0
11
0.00
0.21
0.0
4.5
—
43.5
—
0
11
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
10
0.00
0.21
0.0
2.2
—
12.7
—
0
10
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
43
1.17
0.21
2.0
3.5
e9/l
3.8
4.4
—
5
43
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
269
2646
1.09
0.21
4.0
3.6
mmol/l
1.4
1.3
1.05
256
2483
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
49
1.23
0.20
2.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
21
184
1.15
0.19
7.0
3.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
22
194
1.14
0.19
3.0
2.4
ml/min/173m2
71.0
69.2
—
10
84
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
174
0.86
0.18
1.8
2.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
70
1.15
0.16
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
72
1.11
0.16
1.3
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
66
626
1.07
0.15
4.8
3.3
mg/l
1134.8
167.6
0.42
39
415
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
274
2772
0.94
0.15
4.8
4.3
mmol/l
2.8
2.9
0.28
262
2600
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
83
1.09
0.14
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
11
93
1.19
0.14
10.5
4.9
%
1.0
0.9
0.34
11
87
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
441
1.08
0.14
1.3
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
160
1.13
0.14
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
244
2473
0.95
0.13
5.7
4.9
mmol/mol
40.0
39.2
0.51
229
2341
(3002179) Metamyelocytes/100 leukocytes in Blood
21
190
1.11
0.13
3.7
4.9
%
0.9
0.4
—
8
47
(3022145) Colonoscopy Study observation
31
287
1.09
0.13
1.4
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
67
700
0.95
0.12
1.6
1.7
mmol/l
1.4
1.4
0.05
59
609
(3017181) Myelocytes/100 leukocytes in Blood
23
211
1.10
0.11
3.4
4.9
%
1.0
0.8
—
10
67
(46235355) HIV 1 and 2 tests - Meaningful Use set
63
605
1.05
0.10
2.2
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
74
714
1.05
0.10
4.3
3.1
mmol/l
7.7
8.2
0.45
67
618
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
45
1.11
0.10
2.0
4.0
%
57.0
57.2
—
5
45
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
400
0.94
0.09
2.2
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
54
1.11
0.09
1.0
1.0
—
—
—
0
0
(4010399)
19
175
1.09
0.08
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
120
1175
1.03
0.08
2.6
2.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
195
1.08
0.08
3.5
5.1
%
0.2
0.2
—
10
61
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
88
1.14
0.08
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
88
1.14
0.08
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
88
1.14
0.08
1.4
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
65
1.08
0.08
1.9
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
40
382
1.05
0.08
1.6
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
68
1.03
0.08
1.1
1.2
—
3.5
—
0
11
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
84
0.83
0.07
1.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
86
1.05
0.07
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
68
661
1.04
0.07
5.6
4.0
mg/mmol
11.3
10.4
0.06
39
436
(3011288) Drugs identified in Urine by Screen method
8
95
0.84
0.06
4.3
2.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
95
0.84
0.06
1.5
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
272
2738
0.96
0.06
4.4
4.0
mmol/l
4.7
4.7
0.48
261
2585
(3019150) Specific gravity of Urine by Refractometry
59
574
1.03
0.05
3.3
3.4
kg/l
1.0
1.0
0.01
17
65
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
110
1.09
0.05
7.0
2.6
%
0.9
1.3
0.88
12
110
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
270
0.96
0.03
5.9
6.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
12
128
0.94
0.02
1.4
1.8
mu/l
176.6
318.2
3.54
12
119
(3028300) Cannabinoids [Presence] in Urine
14
148
0.94
0.02
1.2
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
260
2610
0.98
0.02
4.6
3.9
mmol/l
5.9
5.9
0.28
243
2439
(3019832) Treponema pallidum Ab [Presence] in Serum
32
312
1.03
0.02
1.9
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
147
0.95
0.01
1.2
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
147
0.95
0.01
1.2
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
147
0.95
0.01
1.2
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
272
2727
0.99
0.01
4.3
4.0
mmol/l
1.4
1.4
0.61
258
2561
(3016879) Cocaine [Presence] in Urine
14
134
1.05
0.00
1.2
1.9
—
—
—
0
0
(1002224) Polysomnography panel
15
156
0.96
0.00
1.2
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
131
0.99
0.00
1.3
2.6
e6/l
0.1
0.1
0.01
13
124
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
161
0.99
0.00
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
29
289
1.00
0.00
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
103
0.97
0.00
2.4
2.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
113
0.97
0.00
3.5
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
114
0.96
0.00
2.9
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
166
1.03
0.00
1.4
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
56
0.89
0.00
1.2
1.3
—
51.2
—
0
6
(3049717) Cytology report of Urine Cyto stain
7
70
1.00
0.00
1.9
2.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
66
0.91
0.00
1.3
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
69
1.01
0.00
1.1
1.2
—
8.5
—
0
14
(3043409) Potassium [Moles/volume] in Arterial blood
6
59
1.02
0.00
8.5
3.2
mmol/l
4.0
3.8
—
6
51
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
52
0.96
0.00
1.0
1.1
—
0.6
—
0
22
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
62.6
—
0
5
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.9
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
91
0.99
0.00
1.6
1.7
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
1.3
—
0
6
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
66
0.91
0.00
1.3
1.4
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.0
—
6.1
—
0
9
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
67
0.89
0.00
1.3
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
94
0.96
0.00
1.7
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
200
1.00
0.00
1.1
1.2
iu/ml
263.3
157.9
—
6
80
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
35.5
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_MASTACU and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_MASTACU | 1.511 [1.14, 2.01] | 0.004 |
| Birth year | 0.996 [0.99, 1.0] | 0.347 |
During the follow-up period (1.1.1998 — 31.12.2019), 63 out of 695 females with H8_MASTACU died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_MASTACU | 1.681 [1.23, 2.29] | 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 95 out of 630 males with H8_MASTACU died.
Mortality risk
Mortality risk for people of age
years, who have H8_MASTACU.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.155% | 0.291% |
| 5 | 0.85% | 1.9% |
| 10 | 2.049% | 4.692% |
| 15 | 4.027% | 8.837% |
| 20 | 7.316% | 14.976% |
Relationships between endpoints
↥Index endpoint: H8_MASTACU – Acute mastoiditis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data